SVIR epidemic models with vaccination strategies X Liu, Y Takeuchi, S Iwami Journal of Theoretical biology 253 (1), 1-11, 2008 | 332 | 2008 |
Avian–human influenza epidemic model S Iwami, Y Takeuchi, X Liu Mathematical biosciences 207 (1), 1-25, 2007 | 258 | 2007 |
Epidermal growth factor receptor is a host-entry cofactor triggering hepatitis B virus internalization M Iwamoto, W Saso, R Sugiyama, K Ishii, M Ohki, S Nagamori, R Suzuki, ... Proceedings of the National Academy of Sciences 116 (17), 8487-8492, 2019 | 234 | 2019 |
Cell-to-cell infection by HIV contributes over half of virus infection S Iwami, JS Takeuchi, S Nakaoka, F Mammano, F Clavel, H Inaba, ... Elife 4, e08150, 2015 | 170 | 2015 |
A heart–brain–kidney network controls adaptation to cardiac stress through tissue macrophage activation K Fujiu, M Shibata, Y Nakayama, F Ogata, S Matsumoto, K Noshita, ... Nature medicine 23 (5), 611-622, 2017 | 156 | 2017 |
Sporadic on/off switching of HTLV-1 Tax expression is crucial to maintain the whole population of virus-induced leukemic cells M Mahgoub, J Yasunaga, S Iwami, S Nakaoka, Y Koizumi, K Shimura, ... Proceedings of the National Academy of Sciences 115 (6), E1269-E1278, 2018 | 153 | 2018 |
Lymph nodes harbor viral reservoirs that cause rebound of plasma viremia in SIV-infected macaques upon cessation of combined antiretroviral therapy M Horiike, S Iwami, M Kodama, A Sato, Y Watanabe, M Yasui, Y Ishida, ... Virology 423 (2), 107-118, 2012 | 140 | 2012 |
Optimal control strategy for prevention of avian influenza pandemic E Jung, S Iwami, Y Takeuchi, TC Jo Journal of theoretical biology 260 (2), 220-229, 2009 | 140 | 2009 |
Potential anti-COVID-19 agents, cepharanthine and nelfinavir, and their usage for combination treatment H Ohashi, K Watashi, W Saso, K Shionoya, S Iwanami, T Hirokawa, ... Iscience 24 (4), 2021 | 132 | 2021 |
A quantitative model used to compare within-host SARS-CoV-2, MERS-CoV, and SARS-CoV dynamics provides insights into the pathogenesis and treatment of SARS-CoV-2 KS Kim, K Ejima, S Iwanami, Y Fujita, H Ohashi, Y Koizumi, Y Asai, ... PLoS biology 19 (3), e3001128, 2021 | 121 | 2021 |
APOBEC3D and APOBEC3F potently promote HIV-1 diversification and evolution in humanized mouse model K Sato, JS Takeuchi, N Misawa, T Izumi, T Kobayashi, Y Kimura, S Iwami, ... PLoS pathogens 10 (10), e1004453, 2014 | 95 | 2014 |
Avian flu pandemic: can we prevent it? S Iwami, Y Takeuchi, X Liu Journal of theoretical biology 257 (1), 181-190, 2009 | 90 | 2009 |
The machinery for endocytosis of epidermal growth factor receptor coordinates the transport of incoming hepatitis B virus to the endosomal network M Iwamoto, W Saso, K Nishioka, H Ohashi, R Sugiyama, A Ryo, M Ohki, ... Journal of Biological Chemistry 295 (3), 800-807, 2020 | 79 | 2020 |
Vpu augments the initial burst phase of HIV-1 propagation and downregulates BST2 and CD4 in humanized mice K Sato, N Misawa, M Fukuhara, S Iwami, DS An, M Ito, Y Koyanagi Journal of virology 86 (9), 5000-5013, 2012 | 79 | 2012 |
Factors associated with COVID-19 vaccine booster hesitancy: A retrospective cohort study, Fukushima vaccination community survey M Yoshida, Y Kobashi, T Kawamura, Y Shimazu, Y Nishikawa, F Omata, ... Vaccines 10 (4), 515, 2022 | 71 | 2022 |
Multidrug treatment with nelfinavir and cepharanthine against COVID-19 H Ohashi, K Watashi, W Saso, K Shionoya, S Iwanami, T Hirokawa, ... BioRxiv, 2020.04. 14.039925, 2020 | 70 | 2020 |
A method to determine the duration of the eclipse phase for in vitro infection with a highly pathogenic SHIV strain Y Kakizoe, S Nakaoka, CAA Beauchemin, S Morita, H Mori, T Igarashi, ... Scientific reports 5 (1), 10371, 2015 | 62 | 2015 |
Dynamical properties of autoimmune disease models: tolerance, flare-up, dormancy S Iwami, Y Takeuchi, Y Miura, T Sasaki, T Kajiwara Journal of theoretical biology 246 (4), 646-659, 2007 | 61 | 2007 |
Estimation of the incubation period of COVID-19 using viral load data K Ejima, KS Kim, C Ludema, AI Bento, S Iwanami, Y Fujita, H Ohashi, ... Epidemics 35, 100454, 2021 | 56 | 2021 |
Quantifying antiviral activity optimizes drug combinations against hepatitis C virus infection Y Koizumi, H Ohashi, S Nakajima, Y Tanaka, T Wakita, AS Perelson, ... Proceedings of the National Academy of Sciences 114 (8), 1922-1927, 2017 | 56 | 2017 |